Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032

Artificial Intelligence (AI) In Clinical Trials Market 2023 – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Application (Oncology, Neurological Disease And Condition, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Immunology Disease, Other Applications), By End-User (Pharmaceutical And Biotechnology Company, Contract Research Organizations, Other End-Users), And By Region, Opportunities And Strategies – Global Forecast To 2032

Name: Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Artificial Intelligence (AI) In Clinical Trials Global Market Opportunities And Strategies To 2032

Starting Price : $4000.00 $2800.00 | Pages : 276 | Published : March 2024 | | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Artificial Intelligence (AI) In Clinical Trials Market Definition

Artificial Intelligence (AI) in clinical trials refers to the application of advanced computing technologies, particularly AI algorithms and machine learning techniques, to streamline and enhance various aspects of the clinical trial process in the field of healthcare and medicine. Clinical trials are research studies conducted to evaluate the safety and efficacy of new medical interventions, such as drugs, devices or treatments, before they are approved for widespread use.

The artificial intelligence (AI) in clinical trials market consists of sales, by entities (organizations, sole traders and partnerships), of AI software and services that are used to design efficient and adequate clinical trials to improve trial design and optimization through predictions about patient behavior and drug efficacy.

Book your 30 minutes free consultation with our research experts

Artificial Intelligence (AI) In Clinical Trials Market Size

The global artificial intelligence (AI) in clinical trials market reached a value of nearly $3,374.6 million in 2022, having grown at a compound annual growth rate (CAGR) of 39.9% since 2017. The market is expected to grow from $3,374.6 million in 2022 to $20,095.9 million in 2027 at a rate of 42.9%. The market is then expected to grow at a CAGR of 31.1% from 2027 and reach $77,951.2 million in 2032.

Growth in the historic period resulted from rising prevalence of chronic diseases across the globe and growing demand for personalized medicine. Factors that negatively affected growth in the historic period were shortage of skilled artificial intelligence workers and high failure rate of AI projects.

Going forward, the growing need to curb clinical trial costs, increasing healthcare expenditure, increase in the patient pool and growing government support to AI development will drive the growth. Factor that could hinder the growth of the artificial intelligence (AI) in clinical trials market in the future include complexities in adopting AI systems.

Artificial Intelligence (AI) In Clinical Trials Market Drivers

The key drivers of the artificial intelligence (AI) in clinical trials market include:

Growing Need To Curb Clinical Trial Costs

The growing need to curb clinical trial costs is expected to propel the growth of artificial intelligence in the clinical trial market going forward. Drug development and other clinical trial processes are costly by nature and artificial intelligence can be used to provide better drug discovery, better design and safer clinical trials, as well as improve patient outcomes at lower costs. For instance, in February 2023, according to Genetic Engineering and Biotechnology News, a US-based platform that provides the latest information on genetic engineering and biotechnology, developing a new drug among the top 20 global biopharma companies rose by 15%, from $298 million in 2022, to approximately $2.3 billion in 2023, and this includes the costs incurred from developing a drug through clinical trials. Furthermore, in January 2023, according to a report published by the National Bureau of Economic Research (NBER), a US-based non-profit economic research organization, the adoption of AI within the next five years is expected to generate substantial cost savings in healthcare, ranging from 5 to 10% of healthcare spending, equating to approximately $200 billion to $360 billion in annual savings. Therefore, the growing need to curb clinical trial costs will drive the artificial intelligence (AI) in the clinical trial market.

Artificial Intelligence (AI) In Clinical Trials Market Restraints

The key restraints on the artificial intelligence (AI) in clinical trials market include:

Complexities In Adopting AI Systems

The complexities in adopting AI systems are expected to restrain the growth of the AI in clinical trials market during the forecast period. Creating or deploying an artificial intelligence system for a healthcare firm can be costly. As such, many healthcare providers may limit themselves from adopting such services. Resistance to change is another major hindering factor for the market; healthcare professionals may resist changing their existing system to an AI-operated system that requires less human intervention. Moreover, lack of standardization of AI models is another major restraint for the market. Healthcare data is often unstructured and varies across different institutions, making it difficult to create robust and generalizable AI solutions. All these factors limit the adoption of Ai solutions in the healthcare industry, by creating a major restraint for the market. Therefore, the complexities in adopting AI systems may hamper the growth of the AI in clinical trials market. ',

Artificial Intelligence (AI) In Clinical Trials Market Trends

Major trends shaping the artificial intelligence (AI) in clinical trials market include:

Introduction Of Cloud-Based Clinical Trial Platforms To Enable Easy Communication

The introduction of cloud-based clinical trial platforms is a key trend in the artificial intelligence (AI) in clinical trials market, due to their advantages in improving the efficiency of clinical trials. The integration of cloud-based platforms revolutionizes clinical trials, by enhancing collaboration, data accessibility and efficiency in healthcare research. For example, in September 2023, Belong.Life, a US-based company that is the creator of a social network and navigator app for cancer patients, caregivers and healthcare professionals, launched Tara, a software-as-a service (SaaS)-based conversational AI cancer clinical trial matching platform. Tara is a cloud-based software application, designed to help patients find eligible clinical trials more quickly and easily. It uses Belong.Life's proprietary conversational AI technology, machine learning (ML) and natural language processing (NLP) algorithms, to analyze all available cancer clinical trials around the globe in real-time and match patients based on their unique situation and geographical location. The technology can be embedded into websites, mobile apps or text messaging platforms, to enable easy communication with opt-in patients.

Innovative Product Offerings To Clinical Trials With Advanced Data And Technology Platforms

Major companies in the artificial intelligence (AI) in clinical trials market have recently introduced innovative product offerings, such as advanced data and technology platforms, to strengthen their position in the market. For instance, in January 2023, Elligo Health Research Inc., a US-based healthcare enabling research organization, launched DataAI Connect, an innovative data and technology platform that enables rapid, data-driven clinical research. The platform effortlessly gathers, manages, evaluates and shares real-world patient data, presenting a comprehensive strategy to overcome clinical trial obstacles, instead of acting as an accessory technology. This adaptable and sustainable platform includes an all-in-one solution for retrieving and evaluating medical records. It adeptly transforms data into practical insights and individual patient progress information, leveraging cutting-edge technologies such as NLP, ML and clinical acumen.

Opportunities And Recommendations In The Artificial Intelligence (AI) In Clinical Trials Market

Opportunities – The top opportunities in the artificial intelligence (AI) in clinical trials market segmented by offering will arise in the software segment, which will gain $10,843.1 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in clinical trials market segmented by application will arise in the cardiovascular disease segment, which will gain $4,920.4 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in clinical trials market segmented by end-user will arise in the pharmaceutical and biotechnology company segment, which will gain $11,153.2 million of global annual sales by 2027. The top opportunities in the artificial intelligence (AI) in clinical trials market segmented by process will arise in the trial design segment, which will gain $7,017.8 million of global annual sales by 2027. The artificial intelligence (AI) in clinical trials market size will gain the most in USA at $4,758.1 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the artificial intelligence (AI) in clinical trials companies to focus on cloud-based clinical trial platforms, focus on innovative product offerings to clinical trials with advanced data and technology platforms, focus on integration of real-world evidence (RWE) solutions, focus on increasing investments to expand digital patient engagement programs, focus on strategic partnerships and collaborations to develop new products, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions, continue to target fast-growing end users and continue to target fast-growing applications.

Artificial Intelligence (AI) In Clinical Trials Market Segmentation

The artificial intelligence (AI) in clinical trials market is segmented by offering, by process, by application and by end-user.

By Type –
The artificial intelligence (AI) in clinical trials market is segmented by offering into:

a) Software
b) Services

The software market was the largest segment of the artificial intelligence (AI) in clinical trials market segmented by offering, accounting for 67.5% or $2,277.4 million of the total in 2022. Going forward, the services segment is expected to be the fastest growing segment in the artificial intelligence (AI) in clinical trials market segmented by offering, at a CAGR of 44.8%.

By Process –
The artificial intelligence (AI) in clinical trials market is segmented by process into:

a) Trial Design
b) Patient Selection
c) Site Selection
d) Patient Monitoring

The trial design market was the largest segment of the artificial intelligence (AI) in clinical trials market segmented by process, accounting for 42.5% or $1,434.2 million of the total in 2022. Going forward, the patient monitoring segment is expected to be the fastest growing segment in the artificial intelligence (AI) in clinical trials market segmented by process, at a CAGR of 47.9%.

By Application –
The artificial intelligence (AI) in clinical trials market is segmented by application into:

a) Oncology
b) Neurological Disease And Condition
c) Cardiovascular Disease
d) Metabolic Disease
e) Infectious Disease
f) Immunology Disease
g) Other Applications

The oncology market was the largest segment of the artificial intelligence (AI) in clinical trials market segmented by application, accounting for 27.7% or $933.9 million of the total in 2022. Going forward, the cardiovascular disease segment is expected to be the fastest growing segment in the artificial intelligence (AI) in clinical trials market segmented by application, at a CAGR of 52.0%.

By Geography - The artificial intelligence (AI) in clinical trials market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA

• Brazil

• France
• Germany
• UK

• Russia

North America was the largest region in the artificial intelligence (AI) in clinical trials market, accounting for 39.4% or $1,330.2 million of the total in 2022. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the artificial intelligence (AI) in clinical trials market will be Asia Pacific and North America where growth will be at CAGRs of 52.6% and 42.2% respectively. These will be followed by Western Europe and South America where the markets are expected to grow at CAGRs of 39.5% and 33.0% respectively.

Artificial Intelligence (AI) In Clinical Trials Market Market Competitive Landscape

Major Competitors are:

Saama Technologies Inc

Trials. Ai

Innoplexus AG Deep 6 AI Inc Unlearn.AI, Inc

Other Competitors Include:

Mendel Health Inc

AiCure, LLC

Median Technologies

Euretos Services B.V

Antidote Technologies, Inc

SigTuple

Niramai

Qure.ai

PharmEasy

HealthifyMe

MegaRobo

Stonewise

XtalP

Great Bay Bio

Insilico Medicine

MindRank

Leman Biotech

AI Medical Service

Pharos iBio

Neucruit

BenevolentAI

Sensyne Health

Healx

Exscientia

Optellum

Sensing Feeling

Botkin.AI

Skychain Global

ImmunoMind

Infermedica

Molecule.one

Novartis

Ardigen

Tempus

IBM Watson Health

Nference

Cloud Pharmaceuticals

Deep Genomics

BenchSci

Drugtec

Biotech Inteligencia

A21 Ingeniería Clínica

Clinisys

Dasa

ViBe Saúde

Invivo AI

MindAI

Invenómica

Eodyne Systems

GenoSUR

Dataprophet

PhinC Development

Geneticare

Innoplexus

Pontifical Catholic University of Peru - AI Lab

Biocomputacion Peru

Ibis Networks

Aidoc

Zebra Medical Vision

MedyMatch Technology

TechKnowledge

FutureMed

Zulekha Healthcare Group

Imagia

Ibex Medical Analytics

SOPHiA Genetics

Polyganics

Hamad Medical Corporation (HMC)

Qatar Biomedical Research Institute (QBRI)

Potara

IQPay

Melio AI

Xhuma

AstraZeneca

Rology

hearX Group

DilenyTech

1. Executive Summary

2. Table Of Contents

3. List Of Tables

4. List Of Figures

5. Report Structure

6. Market Characteristics

6.1. General Market Definition

6.2. Summary

6.3. Artificial Intelligence (AI) In Clinical Trials Market Definition And Segmentations

6.4. Market Segmentation By Offering

6.4.1. Software

6.4.2. Services

6.5. Market Segmentation By Process

6.5.1. Trial Design

6.5.2. Patient Selection

6.5.3. Site Selection

6.5.4. Patient Monitoring

6.6. Market Segmentation By Application

6.6.1. Oncology

6.6.2. Neurological Disease And Condition

6.6.3. Cardiovascular Disease

6.6.4. Metabolic Disease

6.6.5. Infectious Disease

6.6.6. Immunology Disease

6.6.7. Other Applications

6.7. Market Segmentation By End-User

6.7.1. Pharmaceutical And Biotechnology Company

6.7.2. Contract Research Organizations

6.7.3. Other End-Users

7. Major Market Trends

7.1. Introduction Of Cloud-Based Clinical Trial Platforms To Enable Easy Communication

7.2. Innovative Product Offerings To Clinical Trials With Advanced Data And Technology Platforms

7.3. Integration Of Real-World Evidence (RWE) Solutions, Pioneering Patient-Centric Advancements In Clinical Research And Digital Services

7.4. Strategic Partnerships And Collaborations To Develop New Products

7.5. Increasing Investments To Expand Digital Patient Engagement Programs

8. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario

8.1. COVID-19 Impact On The Artificial Intelligence (AI) In Clinical Trials Market

8.2. Impact Of The War In Ukraine On The Artificial Intelligence (AI) In Clinical Trials Market

8.3. Impact Of High Inflation On The Artificial Intelligence (AI) In Clinical Trials Market

9. Global Market Size and Growth

9.1. Market Size

9.2. Historic Market Growth, 2017 – 2022, Value ($ Million)

9.2.1. Market Drivers 2017 – 2022

9.2.2. Market Restraints 2017 – 2022

9.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)

9.3.1. Market Drivers 2022 – 2027

9.3.2. Market Restraints 2022 – 2027

10. Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation

10.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

10.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

10.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

10.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

11. Artificial Intelligence (AI) In Clinical Trials Market, Regional and Country Analysis

11.1. Global Artificial Intelligence (AI) In Clinical Trials Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

11.2. Global Artificial Intelligence (AI) In Clinical Trials Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12. Asia-Pacific Market

12.1. Summary

12.1.1. Market Overview

12.1.2. Region Information

12.1.3. Market Information

12.1.4. Background Information

12.1.5. Government Initiatives

12.1.6. Regulations

12.1.7. Regulatory Bodies

12.1.8. Major Associations

12.1.9. Taxes Levied

12.1.10. Corporate Tax Structure

12.1.11. Investments

12.1.12. Major Companies

12.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.5. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis

12.6. China Market

12.7. Summary

12.7.1. Market Overview

12.7.2. Country Information

12.7.3. Market Information

12.7.4. Background Information

12.7.5. Government Initiatives

12.7.6. Regulations

12.7.7. Regulatory Bodies

12.7.8. Major Associations

12.7.9. Taxes Levied

12.7.10. Corporate Tax Structure

12.7.11. Investments

12.7.12. Major Companies

12.8. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.9. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.10. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.11. India Market

12.12. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.13. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.14. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.15. Japan Market

12.16. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.17. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.18. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.19. Australia Market

12.20. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.21. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.22. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.23. Indonesia Market

12.24. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.25. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.26. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.27. South Korea Market

12.28. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.29. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

12.30. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13. Western Europe Market

13.1. Summary

13.1.1. Market Overview

13.1.2. Region Information

13.1.3. Market Information

13.1.4. Background Information

13.1.5. Government Initiatives

13.1.6. Regulations

13.1.7. Regulatory Bodies

13.1.8. Major Associations

13.1.9. Taxes Levied

13.1.10. Corporate Tax Structure

13.1.11. Investments

13.1.12. Major Companies

13.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.5. Western Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis

13.6. UK Market

13.7. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.8. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.9. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.10. Germany Market

13.11. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.12. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.13. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.14. France Market

13.15. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.16. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.17. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.18. Italy Market

13.19. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.20. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.21. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.22. Spain Market

13.23. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.24. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

13.25. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14. Eastern Europe Market

14.1. Summary

14.1.1. Market Overview

14.1.2. Region Information

14.1.3. Market Information

14.1.4. Background Information

14.1.5. Government Initiatives

14.1.6. Regulations

14.1.7. Regulatory Bodies

14.1.8. Major Associations

14.1.9. Taxes Levied

14.1.10. Corporate Tax Structure

14.1.11. Investments

14.1.12. Major Companies

14.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.5. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis

14.6. Russia Market

14.7. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.8. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

14.9. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15. North America Market

15.1. Summary

15.1.1. Market Overview

15.1.2. Region Information

15.1.3. Market Information

15.1.4. Background Information

15.1.5. Government Initiatives

15.1.6. Regulations

15.1.7. Regulatory Bodies

15.1.8. Major Associations

15.1.9. Taxes Levied

15.1.10. Corporate Tax Structure

15.1.11. Investments

15.1.12. Major Companies

15.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.5. North America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis

15.6. USA Market

15.7. Summary

15.7.1. Market Overview

15.7.2. Country Information

15.7.3. Market Information

15.7.4. Background Information

15.7.5. Government Initiatives

15.7.6. Regulations

15.7.7. Regulatory Bodies

15.7.8. Major Associations

15.7.9. Taxes Levied

15.7.10. Corporate Tax Structure

15.7.11. Investments

15.7.12. Major Companies

15.8. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.9. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.10. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.11. Canada Market

15.12. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.13. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

15.14. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16. South America Market

16.1. Summary

16.1.1. Market Overview

16.1.2. Region Information

16.1.3. Market Information

16.1.4. Background Information

16.1.5. Government Initiatives

16.1.6. Regulations

16.1.7. Regulatory Bodies

16.1.8. Major Associations

16.1.9. Taxes Levied

16.1.10. Corporate Tax Structure

16.1.11. Investments

16.1.12. Major Companies

16.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.5. South America Artificial Intelligence (AI) In Clinical Trials Market: Country Analysis

16.6. Brazil Market

16.7. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.8. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

16.9. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17. Middle East Market

17.1. Summary

17.1.1. Market Overview

17.1.2. Region Information

17.1.3. Market Information

17.1.4. Background Information

17.1.5. Government Initiatives

17.1.6. Regulations

17.1.7. Regulatory Bodies

17.1.8. Major Associations

17.1.9. Taxes Levied

17.1.10. Corporate Tax Structure

17.1.11. Investments

17.1.12. Major Companies

17.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

17.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18. Africa Market

18.1. Summary

18.1.1. Market Overview

18.1.2. Region Information

18.1.3. Market Information

18.1.4. Background Information

18.1.5. Government Initiatives

18.1.6. Regulations

18.1.7. Regulatory Bodies

18.1.8. Major Associations

18.1.9. Taxes Levied

18.1.10. Corporate Tax Structure

18.1.11. Investments

18.1.12. Major Companies

18.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

18.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)

19. Competitive Landscape and Company Profiles

19.1. Company Profiles

19.2. Saama Technologies Inc.

19.2.1. Company Overview

19.2.2. Products And Services

19.2.3. Business Strategy

19.2.4. Financial Performance

19.3. Trials.Ai

19.3.1. Company Overview

19.3.2. Products And Services

19.3.3. Financial performance

19.4. Innoplexus AG

19.4.1. Company Overview

19.4.2. Products And Services.

19.4.3. Business Strategy

19.4.4. Financial performance

19.5. Deep 6 AI Inc

19.5.1. Company Overview

19.5.2. Products And Services.

19.5.3. Business Strategy

19.5.4. Financial performance

19.6. Unlearn.AI, Inc

19.6.1. Company Overview

19.6.2. Products And Services

19.6.3. Business Strategy

19.6.4. Financial performance

20. Key Mergers And Acquisitions

20.1. Recursion Acquired Cyclica and Valence

20.2. ZS Acquired Trials.ai

20.3. BioNTech Acquired InstaDeep

20.4. Beckman Coulter Diagnostics Acquired StoCastic, LLC

20.5. Bioclinica Acquired Saliency

21. Opportunities And Strategies

21.1. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Countries Offering Most New Opportunities

21.2. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Segments Offering Most New Opportunities

21.3. Global Artificial Intelligence (AI) In Clinical Trials Market In 2027 – Growth Strategies

21.3.1. Market Trend Based Strategies

21.3.2. Competitor Strategies

22. Artificial Intelligence (AI) In Clinical Trials Market, Conclusions And Recommendations

22.1. Conclusions

22.2. Recommendations

22.2.1. Product

22.2.2. Place

22.2.3. Price

22.2.4. Promotion

22.2.5. People

23. Appendix

23.1. Geographies Covered

23.2. Market Data Sources

23.3. Research Methodology

23.4. Currencies

23.5. The Business Research Company

23.6. Copyright and Disclaimer

List Of Tables

Table 1: Global Artificial Intelligence (AI) In Clinical Trials Market, Historic, 2017 – 2022, $ Million

Table 2: Global Artificial Intelligence (AI) In Clinical Trials Market, Forecast, 2022 – 2027, 2032F, $ Million

Table 3: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 4: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 7: Global Artificial Intelligence (AI) In Clinical Trials Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 8: Global Artificial Intelligence (AI) In Clinical Trials Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 9: Asia-Pacific GDP Per Capita, By Country, 2017-2022, $

Table 10: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 11: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 12: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 13: China GDP Per Capita, 2017-2022, $

Table 14: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 15: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 16: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 17: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 18: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 19: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 20: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 21: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 22: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 23: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 24: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 25: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 26: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 27: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 28: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 29: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 30: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 31: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 32: Western Europe GDP Per Capita, By Country, 2017-2022, $

Table 33: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 34: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 35: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 36: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 37: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 38: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 39: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 40: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 41: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 42: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 43: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 44: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 45: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 46: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 47: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 48: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 49: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 50: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 51: Eastern Europe GDP Per Capita, By Country, 2017-2022, $

Table 52: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 53: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 54: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 55: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 56: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 57: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 58: North America GDP Per Capita, By Country, 2017-2022, $

Table 59: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 60: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 61: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 62: USA GDP Per Capita, 2017-2022, $

Table 63: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 64: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 65: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 66: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 67: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 68: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 69: South America GDP Per Capita, By Country, 2017-2022, $

Table 70: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 71: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 72: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 73: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 74: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 75: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 76: Middle East GDP Per Capita, By Country, 2017-2022, $

Table 77: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 78: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 79: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 80: Africa GDP Per Capita, By Country, 2017-2022, $

Table 81: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 82: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 83: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Table 84: Global Artificial Intelligence (AI) In Clinical Trials Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)

Table 85: Saama Technologies, Inc – Financial Performance, 2022, $ Million

Table 86: Trials.Ai – Financial performance, 2022, $ Million

Table 87: Innoplexus AG – Financial performance, 2022, $ Million

Table 88: Deep 6 AI Inc – Financial performance, 2022, $ Million

Table 89: Unlearn.AI, Inc – Financial performance, 2022, $ Million

Table 90: Global Artificial Intelligence (AI) In Clinical Trials Market Size Gain ($ Million), 2022 – 2027, By Country

Table 91: Global Artificial Intelligence (AI) In Clinical Trials Market Size Gain ($ Million), Segmentation By Offering, 2022 – 2027

Table 92: Global Artificial Intelligence (AI) In Clinical Trials Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027

Table 93: Global Artificial Intelligence (AI) In Clinical Trials Market Size Gain ($ Million), Segmentation By End-User, 2022 – 2027

Table 94: Global Artificial Intelligence (AI) In Clinical Trials Market Size Gain ($ Million), Segmentation By Process, 2022 – 2027

Table 95: Artificial Intelligence (AI) In Clinical Trials Market Data Sources

List Of Figures

Figure 1: Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation By Offering

Figure 2: Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation By Process

Figure 3: Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation By Application

Figure 4: Global Artificial Intelligence (AI) In Clinical Trials Market Segmentation By End-User

Figure 5: Global Artificial Intelligence (AI) In Clinical Trials Market, Historic, 2017 – 2022, $ Million

Figure 6: Global Artificial Intelligence (AI) In Clinical Trials Market, Forecast, 2022 – 2027, 2032F, $ Million

Figure 7: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 8: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 9: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 10: Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 11: Global Artificial Intelligence (AI) In Clinical Trials Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 12: Global Artificial Intelligence (AI) In Clinical Trials Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 13: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 14: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 15: Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 16: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 17: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 18: China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 19: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 20: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 21: India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 22: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 23: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 24: Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 25: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 26: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 27: Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 28: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 29: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 30: Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 31: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 32: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 33: South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 34: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 35: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 36: Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 37: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 38: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 39: UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 40: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 41: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 42: Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 43: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 44: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 45: France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 46: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 47: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 48: Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 49: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 50: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 51: Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 52: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 53: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 54: Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 55: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 56: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 57: Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 58: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 59: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 60: North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 61: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 62: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 63: USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 64: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 65: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 66: Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 67: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 68: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 69: South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 70: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 71: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 72: Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 73: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 74: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 75: Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 76: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 77: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 78: Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million

Figure 79: Global Artificial Intelligence (AI) In Clinical Trials Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)

Figure 80: Geographic Regions Covered